Hana Pharm Co., Ltd. (KRX: 293480)
South Korea
· Delayed Price · Currency is KRW
11,160
-40 (-0.36%)
Oct 14, 2024, 3:19 PM KST
Hana Pharm Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2017 | FY 2016 |
| Oct '24 Oct 11, 2024 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
| Debt / Equity Ratio | 0.36 | 0.36 | 0.56 |
| Debt / EBITDA Ratio | 0.82 | 0.82 | 1.13 |
| Debt / FCF Ratio | 1.91 | 1.91 | 7.45 |
| Asset Turnover | 1.09 | 1.09 | - |
| Inventory Turnover | 2.43 | 2.43 | - |
| Quick Ratio | 1.22 | 1.22 | 1.23 |
| Current Ratio | 1.63 | 1.63 | 1.77 |
| Return on Equity (ROE) | 35.53% | 35.53% | - |
| Return on Assets (ROA) | 15.52% | 15.52% | - |
| Return on Capital (ROIC) | 20.21% | 20.21% | - |
| Payout Ratio | 4.21% | 4.21% | - |
| Buyback Yield / Dilution | -39.75% | - |
| Total Shareholder Return | -39.75% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.